10 Years of belimumab experience: What have we learnt?

por Levy, Roger A, Gonzalez-Rivera, Tania, Khamashta, Munther, Fox, Norma Lynn, Jones-Leone, Angela, Rubin, Bernie, Burriss, Susan W, Gairy, Kerry, van Maurik, Andre, Roth, David A
Publicado 2021

Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study

por van Vollenhoven, Ronald F, Stohl, William, Furie, Richard A, Fox, Norma Lynn, Groark, James G, Bass, Damon, Kurtinecz, Milena, Pobiner, Bonnie F, Eastman, William J, Gonzalez‑Rivera, Tania, Gordon, David
Publicado 2018

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus

por Urowitz, Murray B., Aranow, Cynthia, Asukai, Yumi, Bass, Damon L., Bruce, Ian N., Chauhan, Deven, Dall'Era, Maria, Furie, Richard, Fox, Norma Lynn, Gilbride, Jennifer A., Hammer, Anne, Ginzler, Ellen M., Gonzalez‐Rivera, Tania, Levy, Roger A., Merrill, Joan T., Quasny, Holly, Roth, David A., Stohl, William, van Vollenhoven, Ronald, Wallace, Daniel J., Petri, Michelle
Publicado 2022